Condensed Consolidated Statements of Cash Flows (Unaudited)	3 Months Ended
	Aug. 31, 2020 USD ($)
Operating activities:
Net loss	$ (115,883)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity in loss of affiliated company	4,107
Fair value of common stock issued under License Option Agreement	7
Anti-dilution rights derivative liability expense	83,500
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(800)
Accounts payable, accrued expenses and other	(80,853)
Accrued payable to founders	54,766
Net cash used in operating activities	(55,156)
Investing activities:
Net cash, cash equivalents and restricted cash acquired in Reverse Merger	605,215
Net cash provided by investing activities	605,215
Financing activities:
Proceeds from the issuance of Class A common stock	63
Net cash provided by financing activities	63
Net increase in cash, cash equivalents and restricted cash	550,122
Cash, May 31, 2020	500
Cash, cash equivalents and restricted cash, August 31, 2020	550,622
Supplemental Disclosure of Cash Flow Information:
Cash paid for income taxes	0
Supplemental disclosure of non-cash investing activities:
Net liabilities assumed in Reverse Merger, net of cash and restricted cash	$ (230,780)